Autologous hematopoietic stem cell transplantation
According to findings presented at the 2021 ASH Annual Meeting, the combination of daratumumab, carfilzomib, ... The combination of daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell ... A study of patients aged ≥60 years with lymphoma found that a high-dose chemotherapy regimen followed by autologous ... New guidelines from the International Osteoporosis Foundation (IOF) address management of osteoporosis, fracture risk, ... Researchers from the University of British Columbia and Vancouver General Hospital evaluated incidence and risk factors ... Patients with mantle cell lymphoma who are unmarried, have a lower educational level, or with multiple comorbidities are ... A study examined longitudinal trends in the frailty state of blood or bone marrow transplantation (BMT) survivors. The ... Parameswaran Hari, MD, Chief of Hematology/Oncology at the Medical College of Wisconsin, spoke with DocWire News about ... Patients with multiple myeloma (MM) who underwent double autologous hematopoietic cell transplantation (AHCT) did not ... DocWire News spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical ... Findings presented at the 2020 American Society of Hematology Annual Meeting & Exposition suggest that ejection ... A study has found that the addition of rituximab to ixazomib, when used as maintenance therapy following autologous ... Maintenance therapy following autologous hematopoietic cell transplantation (AHCT) did not significantly impact survival ... In light-chain (AL) amyloidosis, a rare plasma cell disease marked by excess deposit of protein in the organs, the goal ... A study presented at the 2020 Society of Hematologic Oncology Annual Meeting found that the addition of ixazomib to ... Researchers compared the efficacy of lenalidomide and dexamethasone paired with carfilzomib or bortezomib for the ... A study published in Blood Advances observed significant differences in the use of novel therapy and autologous ... The U.S. Food and Drug Administration (FDA) approved the combination of Darzalex® (daratumumab) plus Velcade® ... Research presented at the European Hematology Association 24th Congress found that the addition of daratumumab to ... Jonathan U. Peled, MD, of Memorial Sloan Kettering Cancer Center discusses his study which looked at whether pre-HCT ...